Absorption |
Blood-Brain Barrier | BBB+ | 0.9806 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.8553 |
P-glycoprotein Substrate | Non-substrate | 0.6648 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9264 |
Non-inhibitor | 0.9765 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8122 |
Distribution |
Subcellular localization | Mitochondria | 0.5654 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8035 |
CYP450 2D6 Substrate | Non-substrate | 0.8857 |
CYP450 3A4 Substrate | Non-substrate | 0.6950 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8600 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8690 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9238 |
CYP450 2C19 Inhibitor | Inhibitor | 0.5285 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9523 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7688 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9274 |
Non-inhibitor | 0.9397 |
AMES Toxicity | Non AMES toxic | 0.9772 |
Carcinogens | Non-carcinogens | 0.6705 |
Fish Toxicity | High FHMT | 0.8756 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9957 |
Honey Bee Toxicity | High HBT | 0.6857 |
Biodegradation | Ready biodegradable | 0.9449 |
Acute Oral Toxicity | III | 0.9186 |
Carcinogenicity (Three-class) | Non-required | 0.5463 |